Macrophage colony‐stimulating factor and interleukin‐6 release by periprosthetic cells stimulates osteoclast formation and bone resorption
- 1 September 1999
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 17 (5) , 686-694
- https://doi.org/10.1002/jor.1100170510
Abstract
Periprosthetic bone loss is an important contributory factor for aseptic loosening of total joint replacements. It has recently been shown that osteoclast precursor cells are present in the wear particle-associated macrophage infiltrate found in the membrane surrounding loose implants and that these cells are capable of differentiating into osteoclastic bone-resorbing cells. Long-term co-culture of arthroplasty-derived macrophages and the rat osteoblast-like cell line, UMR-106, in the presence of 1,25 (OH)2D3 results in the formation of numerous multinucleated cells that are positive for tartrate-resistant acid phosphatase and vitronectin receptor and capable of extensive lacunar bone resorption. The aim of this study was to determine the effect of cytokines/growth factors, known to be present in the arthroplasty membrane, on this process of osteoclast differentiation. During osteoclast formation, increased levels of macrophage colony-stimulating factor, interleukin-6, and to a lesser extent, interleukin-1β, but not tumour necrosis factor α, were detected in the co-culture supernatants. Addition of neutralising antibodies to human interleukin-1β or tumour necrosis factor α to the co-culture system did not inhibit osteoclast formation. In contrast, co-cultures to which neutralising antibodies to human macrophage colony-stimulating factor or interleukin-6 were added contained fewer cells positive for tartrate-resistant acid phosphatase and vitronectin receptor and formed significantly fewer resorption pits. Time-course studies showed that macrophage colony-stimulating factor and interleukin-6 increase osteoclast formation mainly in the early stages of osteoclast differentiation. These results indicate that the release of macrophage colony-stimulating factor and interleukin-6 by activated cells in the arthroplasty membrane is likely to contribute to pathological bone resorption associated with aseptic loosening by stimulating differentiation of mononuclear phagocyte osteoclast precursors into mature bone-resorbing cells.Keywords
This publication has 38 references indexed in Scilit:
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Regulation of bone cells by particle-activated mononuclear phagocytesThe Journal of Bone and Joint Surgery. British volume, 1997
- Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cellsAnnals of the Rheumatic Diseases, 1997
- In vitro activation of human fibroblasts by retrieved titanium alloy wear debrisJournal of Orthopaedic Research, 1996
- Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cellsEndocrinology, 1994
- Bone resorption activity of particulate-stimulated macrophagesJournal of Bone and Mineral Research, 1993
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.Journal of Clinical Investigation, 1992
- Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitroJournal of Bone and Mineral Research, 1989
- Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.The Journal of Experimental Medicine, 1986